These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 38477525)

  • 1. Advanced Imaging in the Diagnosis and Response Assessment of High-Grade Glioma:
    Hu LS; Smits M; Kaufmann TJ; Knutsson L; Rapalino O; Galldiks N; Sundgrene PC; Cha S
    AJR Am J Roentgenol; 2024 Mar; ():. PubMed ID: 38477525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
    Seeger A; Braun C; Skardelly M; Paulsen F; Schittenhelm J; Ernemann U; Bisdas S
    Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging biomarkers guided anti-angiogenic therapy for malignant gliomas.
    Kong Z; Yan C; Zhu R; Wang J; Wang Y; Wang Y; Wang R; Feng F; Ma W
    Neuroimage Clin; 2018; 20():51-60. PubMed ID: 30069427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
    Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
    Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy of high-grade gliomas: current standards and new concepts, innovations in imaging and radiotherapy, and new therapeutic approaches.
    Dhermain F
    Chin J Cancer; 2014 Jan; 33(1):16-24. PubMed ID: 24384237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of imaging in the management of adults with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.
    Fouke SJ; Benzinger T; Gibson D; Ryken TC; Kalkanis SN; Olson JJ
    J Neurooncol; 2015 Dec; 125(3):457-79. PubMed ID: 26530262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.
    Abrigo JM; Fountain DM; Provenzale JM; Law EK; Kwong JS; Hart MG; Tam WWS
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011551. PubMed ID: 29357120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fully automated analysis combining [
    Paprottka KJ; Kleiner S; Preibisch C; Kofler F; Schmidt-Graf F; Delbridge C; Bernhardt D; Combs SE; Gempt J; Meyer B; Zimmer C; Menze BH; Yakushev I; Kirschke JS; Wiestler B
    Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4445-4455. PubMed ID: 34173008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of MRI-Based Advanced Neuroimaging on Neurooncologists' Clinical Decision-Making in Patients With Posttreatment High-Grade Glioma: A Prospective Survey-Based Study.
    Dagher SA; Liu HL; Ozkara BB; Calle S; Kaya D; Gule-Monroe MK; Chasen NN; Schellingerhout D; Learned KO; Shah KB; Johnson JM; Sun J; Schomer DF; Kumar VA; Wintermark M; Majd NK; Nam JY; Chen MM
    AJR Am J Roentgenol; 2024 Aug; ():. PubMed ID: 39140632
    [No Abstract]   [Full Text] [Related]  

  • 10. Conventional and Advanced Magnetic Resonance Imaging Assessment of Non-Enhancing Peritumoral Area in Brain Tumor.
    Scola E; Del Vecchio G; Busto G; Bianchi A; Desideri I; Gadda D; Mancini S; Carlesi E; Moretti M; Desideri I; Muscas G; Della Puppa A; Fainardi E
    Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Advanced MR Imaging in Diagnosis of Neurological Malignancies: Current Status and Future Perspective.
    Eraky AM; Beck RT; Treffy RW; Aaronson DM; Hedayat H
    J Integr Neurosci; 2023 May; 22(3):73. PubMed ID: 37258452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced imaging techniques for neuro-oncologic tumor diagnosis, with an emphasis on PET-MRI imaging of malignant brain tumors.
    Overcast WB; Davis KM; Ho CY; Hutchins GD; Green MA; Graner BD; Veronesi MC
    Curr Oncol Rep; 2021 Feb; 23(3):34. PubMed ID: 33599882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced MRI assessment of non-enhancing peritumoral signal abnormality in brain lesions.
    Martín-Noguerol T; Mohan S; Santos-Armentia E; Cabrera-Zubizarreta A; Luna A
    Eur J Radiol; 2021 Oct; 143():109900. PubMed ID: 34412007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma.
    de la Fuente MI; Young RJ; Rubel J; Rosenblum M; Tisnado J; Briggs S; Arevalo-Perez J; Cross JR; Campos C; Straley K; Zhu D; Dong C; Thomas A; Omuro AA; Nolan CP; Pentsova E; Kaley TJ; Oh JH; Noeske R; Maher E; Choi C; Gutin PH; Holodny AI; Yen K; DeAngelis LM; Mellinghoff IK; Thakur SB
    Neuro Oncol; 2016 Feb; 18(2):283-90. PubMed ID: 26691210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction of a standardized multimodality image protocol for navigation-guided surgery of suspected low-grade gliomas.
    Mert A; Kiesel B; Wöhrer A; Martínez-Moreno M; Minchev G; Furtner J; Knosp E; Wolfsberger S; Widhalm G
    Neurosurg Focus; 2015 Jan; 38(1):E4. PubMed ID: 25552284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 3 Tesla proton MR spectroscopy, MR perfusion and MR diffusion for distinguishing glioma recurrence from posttreatment effects.
    Fink JR; Carr RB; Matsusue E; Iyer RS; Rockhill JK; Haynor DR; Maravilla KR
    J Magn Reson Imaging; 2012 Jan; 35(1):56-63. PubMed ID: 22002882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic performance of advanced MRI in differentiating high-grade from low-grade gliomas in a setting of routine service.
    Chawalparit O; Sangruchi T; Witthiwej T; Sathornsumetee S; Tritrakarn S; Piyapittayanan S; Chaicharoen P; Direksunthorn T; Charnchaowanish P
    J Med Assoc Thai; 2013 Oct; 96(10):1365-73. PubMed ID: 24350420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective Longitudinal Analysis of 2-Hydroxyglutarate Magnetic Resonance Spectroscopy Identifies Broad Clinical Utility for the Management of Patients With IDH-Mutant Glioma.
    Choi C; Raisanen JM; Ganji SK; Zhang S; McNeil SS; An Z; Madan A; Hatanpaa KJ; Vemireddy V; Sheppard CA; Oliver D; Hulsey KM; Tiwari V; Mashimo T; Battiste J; Barnett S; Madden CJ; Patel TR; Pan E; Malloy CR; Mickey BE; Bachoo RM; Maher EA
    J Clin Oncol; 2016 Nov; 34(33):4030-4039. PubMed ID: 28248126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional arterial spin labeling imaging and dynamic susceptibility contrast perfusion-weighted imaging value in diagnosing glioma grade prior to surgery.
    Ma H; Wang Z; Xu K; Shao Z; Yang C; Xu P; Liu X; Hu C; Lu X; Rong Y
    Exp Ther Med; 2017 Jun; 13(6):2691-2698. PubMed ID: 28587332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.